Ting-Yu Tu

Dr. Ting-Yu Tu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2021 in Journal of Autoimmunity
Verified
Journal Article
Closed access
TTTing-Yu Tu
Ting-Yu Tu
RCRenin Chang
Renin Chang
JLJung-Nien Lai
Jung-Nien Lai
CTChu-Chiao Tseng
Chu-Chiao Tseng
MCMing-Li Chen
Ming-Li Chen
CHENGCHUNG WEICHENGCHUNG WEI
CHENGCHUNG WEI

21 April 2023 in Viruses
Verified
Journal Article
Open access
PDF file
KMKevin Sheng-Kai Ma
Kevin Sheng-Kai Ma
NCNing-Chien Chin
Ning-Chien Chin
TTTing-Yu Tu
Ting-Yu Tu
YWYao-Cheng Wu
Yao-Cheng Wu
HYHei-Tung Yip
Hei-Tung Yip
RCRenin Chang
Renin Chang
Patients with viral infections are susceptible to osteoporosis. This cohort study investigated the correlation between human papillomavirus (HPV) infections and the risk of osteoporosis via 12,936 patients with new-onset HPV infections and propensity score-matched non-HPV controls enrolled in Taiwan. The primary endpoint was incident osteoporosis following HPV infections. Cox proportional hazards regression analysis and the Kaplan-Meier method was used to determine the effect of HPV infections on the risk of osteoporosis. Patients with HPV infections presented with a significantly high risk of osteoporosis (adjusted hazard ratio, aHR = 1.32, 95% CI = 1.06–1.65) after adjusting for sex, age, comorbidities and co-medications. Subgroup analysis provided that populations at risk of HPV-associated osteoporosis were females (aHR = 1.33; 95% CI = 1.04–1.71), those aged between 60 and 80 years (aHR = 1.45, 95% CI = 1.01–2.08 for patients aged 60–70; aHR = 1.51; 95% CI = 1.07–2.12 for patients aged 70–80), and patients with long-term use of glucocorticoids (aHR = 2.17; 95% CI = 1.11–4.22). HPV-infected patients who did not receive treatments for HPV infections were at a greater risk (aHR = 1.40; 95% CI = 1.09–1.80) of osteoporosis, while the risk of osteoporosis in those who received treatments for HPV infections did not reach statistical significance (aHR = 1.14; 95% CI = 0.78–1.66). Patients with HPV infections presented with a high risk of subsequent osteoporosis. Treatments for HPV infections attenuated the risk of HPV-associated osteoporosis.

Verified
Journal Article
Open access
PDF file
Li-Chuan HsuLi-Chuan Hsu
Li-Chuan Hsu
TTTing-Yu Tu
Ting-Yu Tu
HCHui-Yuan Chen
Hui-Yuan Chen
RCRenin Chang
Renin Chang
HYHei-Tung Yip
Hei-Tung Yip
JSJim Sheu
Jim Sheu
Background: This is an investigation of the human papillomavirus (HPV) infection and its correlation with the risk of ectopic pregnancy (EP). Methods: The cohort study includes 11,239 patients with newly diagnosed HPV infections between 2000 and 2012, and by using computer-generated random numbers, patients who do not have HPV infections are selected randomly as the comparison cohort. The HPV infection cohort is matched to comparison individuals at a 1:10 ratio by age and index year. All individuals included in the study were followed up to the point they developed EP, pulled-out from the insurance program, lost to follow-up, or until the end of 2013. A Cox proportional-hazards regression analysis was used to analyze the risk of EP with the hazard ratios (HRs) and 95% confidence intervals (CIs) between the HPV and control cohort. Results: The adjusted hazard ratio (aHR) of EP for HPV patients relative to controls is 1.70 (95% CI = 1.04, 2.78), indicating a positive correlation between EP and HPV in the 13-year follow-up period, after adjusting for age and relevant comorbidities. The sensitivity analyses yield similar results. Conclusions: A history of HPV infection is a potential risk factor associated with the development of subsequent EP in Taiwanese individuals, especially those diagnosed with an HPV infection within 3 years.